Advertisement

2017 Is Banner Year for Drug Approvals by the Food and Drug Administration

      Abstract

      In 2017, the US Food and Drug Administration approved 46 novel drugs, and 29 drugs received newly approved indications. This record setting year was due in part to the new expedited review pathways. A review of these drugs is summarized.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • U.S. Food and Drug Administration
        Novel drug approvals for 2017 [Internet].
        (Silver Spring: U.S. Food and Drug Administration; Available at:)
        • U.S. Food and Drug Administration
        2017 new drug therapy approvals [Internet].
        (Silver Spring: U.S. Food and Drug Administration; Available at:)
        • CenterWatch
        2017 FDA approved drugs [Internet].
        (Boston: CenterWatch; Available at:)
        • U.S. Department of Health and Human Services
        2017: a year of accomplishment [Internet].
        (Washington: U.S. Department of Health and Human Services; Available at:)